Severe Infectious Complications of Intravesical Bacillus Calmette-Guérin: A Case Series of 10 Patients
Author:
Publisher
Elsevier BV
Subject
Urology
Reference24 articles.
1. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO Guideline;Chang;J Urol,2016
2. Efficacy and safety of bacille Calmette-Guerin immunotherapy in superficial bladder cancer;Lamm;Clin Infect Dis,2000
3. Bacillus Calmette-Guerin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature;Perez-Jacoiste Asin;Medicine (Baltimore),2014
4. A cough conundrum in a patient with a previous history of BCG immunotherapy for bladder cancer;Mehta;BMJ Case Rep,2012
5. Fever of unknown origin and pancytopenia caused by culture-proven delayed onset disseminated bacillus Calmette-Guerin (BCG) infection after intravesical instillation;Dammert;BMJ Case Rep,2013
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Post-Bacillus Calmette-Guérin Cystitis: A Systematic Review of the Literature;Current Bladder Dysfunction Reports;2024-05-24
2. Disseminated Bacillus Calmette-Guérin Infection with Rhabdomyolysis, Acute Kidney Injury, and Interstitial Pneumonia after Bacillus Calmette-Guérin Intravesical Instillation Therapy;Internal Medicine;2023-12-15
3. [Fever of Unknown Origin in a Patient Administered With Bacillus Calmette-Guérin (BCG) to Treat Urothelial Vesical Carcinoma in Situ];Clinical Management Issues;2023-07-19
4. Comparison of Sequential Intravesical Gemcitabine and Docetaxel vs Bacillus Calmette-Guérin for the Treatment of Patients With High-Risk Non–Muscle-Invasive Bladder Cancer;JAMA Network Open;2023-02-28
5. Multi-Institution Evaluation of Sequential Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-Guerin Naïve Patients with Non-Muscle Invasive Bladder Cancer;Clinical Genitourinary Cancer;2022-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3